Cutaneous Adverse Reaction After COVID-19 Vaccination

Q4 Medicine

Journal of Mycology and Infection Pub Date : 2022-09-30 DOI:10.17966/jmi.2022.27.3.45

H. D. Kook, Jiyoung Ahn, H. Jung

引用次数: 0

Abstract

As coronavirus disease 2019 (COVID-19) spreads worldwide, various vaccines are being developed against the SARS-CoV-2 virus. These vaccines had to be developed in a relatively short period; therefore, they had to be manufactured using a method different from that of conventional vaccines. In addition, many people were vaccinated in a short period, and various side effects related to vaccination have been reported. In this article, we describe the injection site reactions and some unique skin reactions associated with COVID-19 vaccination, such as drug eruptions, bullous lesions, and foreign body reactions, with their possible causes.

查看原文本刊更多论文

接种新冠肺炎疫苗后的皮肤不良反应

随着2019冠状病毒病（新冠肺炎）在全球范围内传播，针对SARS-CoV-2病毒的各种疫苗正在研发中。这些疫苗必须在相对较短的时间内研发出来；因此，它们必须使用不同于传统疫苗的方法生产。此外，许多人在短时间内接种了疫苗，并报告了与接种疫苗有关的各种副作用。在这篇文章中，我们描述了与新冠肺炎疫苗接种相关的注射部位反应和一些独特的皮肤反应，如药疹、大疱性病变和异物反应及其可能的原因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Mycology and Infection Medicine-Infectious Diseases

CiteScore

0.20

自引率

0.00%

发文量

期刊介绍： The Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods. The journal should be of general interests to the scientific communities at large and should provide medical societies with advanced breadth and depth of mycological expertise. In addition, the journal supplements infectious diseases in adjunct to the field of mycology to address a well-rounded understanding of infectious disorders. The Journal of mycology and infection, which is issued quarterly, in March, June, September and December each year, published in English. The scope of the Journal of mycology and infection includes invited reviews, original articles, case reports, letter to the editor, and images in mycology. The journal is compliant to peer-review/open access and all articles undergo rigorous reviewing processes by our internationally acknowledged team of editorial boards. The articles directed to publication should encompass in-depth materials that employ scholastic values of mycology and various infectious diseases. Articles responding to critical methodology and outcomes which have potential to enhance better understanding of mycology and infectious diseases are also suitable for publication.